Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Sep;98(1):268–274. doi: 10.1111/j.1476-5381.1989.tb16891.x

A dual model for cardiac arrhythmias: coexistence of re-entry and abnormal automaticity and effects of antiarrhythmic agents.

K M Wu 1, T Hunter 1, A Proakis 1
PMCID: PMC1854661  PMID: 2508981

Abstract

1. We have developed a dual model for arrhythmia anaesthetized dogs. The model consists of an inducible re-entrant atrial tachycardia and spontaneous ventricular ectopies in the same heart. 2. The model for re-entrant atrial tachycardia was created by crushing the right atrium longitudinally in the intercaval region and transversely in the front free wall parallel to the atrioventricular groove. Ventricular abnormal automaticity was produced by prior (20 approximately 24 h) left anterior descending coronary artery occlusion. The ventricular arrhythmia was partially suppressed during rapid pacing-induced atrial tachycardia and resumed after atrial re-entry was terminated. 3. Mapping experiments indicate that the atrial tachycardia was due to circus movement occurring in the tissue around the tricuspid ring. This re-entrant circuit was identical to that induced in the model created by the incision method. 4. Clofilium (0.75 mg kg-1, n = 5) increased the cycle length of atrial re-entry by 14 +/- 4% from 139 +/- 12 to 159 +/- 18 ms (P less than 0.05). Flecainide (1.8 +/- 0.9 mg kg-1, n = 5) prolonged the cycle length of the tachycardia by 114 +/- 57% from 158 +/- 11 to 332 +/- 66 ms (P less than 0.05). 5. Both drugs terminated the atrial arrhythmia, but re-entry could be reinduced only in flecainide-treated dogs. Flecainide reduced ventricular ectopies by 89 +/- 19%, whereas clofilium did not change ventricular abnormal automaticity or maximum pacing cycle length that is necessary to overdrive the ventricle fully.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
268

Images in this article

270Figure 1
on p.270

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. El-Sherif N., Gough W. B., Zeiler R. H., Mehra R. Triggered ventricular rhythms in 1-day-old myocardial infarction in the dog. Circ Res. 1983 May;52(5):566–579. doi: 10.1161/01.res.52.5.566. [DOI] [PubMed] [Google Scholar]
  2. Frame L. H., Page R. L., Boyden P. A., Fenoglio J. J., Jr, Hoffman B. F. Circus movement in the canine atrium around the tricuspid ring during experimental atrial flutter and during reentry in vitro. Circulation. 1987 Nov;76(5):1155–1175. doi: 10.1161/01.cir.76.5.1155. [DOI] [PubMed] [Google Scholar]
  3. Frame L. H., Page R. L., Hoffman B. F. Atrial reentry around an anatomic barrier with a partially refractory excitable gap. A canine model of atrial flutter. Circ Res. 1986 Apr;58(4):495–511. doi: 10.1161/01.res.58.4.495. [DOI] [PubMed] [Google Scholar]
  4. Friedman P. L., Stewart J. R., Fenoglio J. J., Jr, Wit A. L. Survival of subendocardial Purkinje fibers after extensive myocardial infarction in dogs. Circ Res. 1973 Nov;33(5):597–611. doi: 10.1161/01.res.33.5.597. [DOI] [PubMed] [Google Scholar]
  5. Friedman P. L., Stewart J. R., Wit A. L. Spontaneous and induced cardiac arrhythmias in subendocardial Purkinje fibers surviving extensive myocardial infarction in dogs. Circ Res. 1973 Nov;33(5):612–626. doi: 10.1161/01.res.33.5.612. [DOI] [PubMed] [Google Scholar]
  6. Hodess A. B., Follansbee W. P., Spear J. F., Moore E. N. Electrophysiological effects of a new antiarrhythmic agent, flecainide, on the intact canine heart. J Cardiovasc Pharmacol. 1979 Jul-Aug;1(4):427–439. doi: 10.1097/00005344-197907000-00005. [DOI] [PubMed] [Google Scholar]
  7. Jewitt D. E., Balcon R., Raftery E. B., Oram S. Incidence and management of supraventricular arrhythmias after acute myocardial infarction. Lancet. 1967 Oct 7;2(7519):734–738. doi: 10.1016/s0140-6736(67)91943-5. [DOI] [PubMed] [Google Scholar]
  8. Kvam D. C., Banitt E. H., Schmid J. R. Antiarrhythmic and electrophysiologic actions of flecainide in animal models. Am J Cardiol. 1984 Feb 27;53(5):22B–25B. doi: 10.1016/0002-9149(84)90497-1. [DOI] [PubMed] [Google Scholar]
  9. Lazzara R., El-Sherif N., Hope R. R., Scherlag B. J. Ventricular arrhythmias and electrophysiological consequences of myocardial ischemia and infarction. Circ Res. 1978 Jun;42(6):740–749. doi: 10.1161/01.res.42.6.740. [DOI] [PubMed] [Google Scholar]
  10. Lazzara R., el-Sherif N., Scherlag B. J. Electrophysiological properties of canine Purkinje cells in one-day-old myocardial infarction. Circ Res. 1973 Dec;33(6):722–734. doi: 10.1161/01.res.33.6.722. [DOI] [PubMed] [Google Scholar]
  11. Mines G. R. On dynamic equilibrium in the heart. J Physiol. 1913 Jul 18;46(4-5):349–383. doi: 10.1113/jphysiol.1913.sp001596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Platia E. V., Reid P. R. Dose-ranging studies of clofilium, an antiarrhythmic quaternary ammonium. Clin Pharmacol Ther. 1984 Feb;35(2):193–202. doi: 10.1038/clpt.1984.26. [DOI] [PubMed] [Google Scholar]
  13. Steinberg M. I., Molloy B. B. Clofilum--a new antifibrillatory agent that selectively increases cellular refractoriness. Life Sci. 1979 Oct 15;25(16):1397–1406. doi: 10.1016/0024-3205(79)90417-x. [DOI] [PubMed] [Google Scholar]
  14. Steinberg M. I., Sullivan M. E., Wiest S. A., Rockhold F. W., Molloy B. B. Cellular electrophysiology of clofilium, a new antifibrillatory agent, in normal and ischemic canine Purkinje fibers. J Cardiovasc Pharmacol. 1981 Jul-Aug;3(4):881–895. doi: 10.1097/00005344-198107000-00022. [DOI] [PubMed] [Google Scholar]
  15. Vik-Mo H., Ohm O. J., Lund-Johansen P. Electrophysiologic effects of flecainide acetate in patients with sinus nodal dysfunction. Am J Cardiol. 1982 Nov;50(5):1090–1094. doi: 10.1016/0002-9149(82)90423-4. [DOI] [PubMed] [Google Scholar]
  16. Wu K. M., Hoffman B. F. Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro. Circulation. 1987 Dec;76(6):1397–1408. doi: 10.1161/01.cir.76.6.1397. [DOI] [PubMed] [Google Scholar]
  17. Wu K. M., Hunter T., Proakis A. Pharmacological characterisation of a re-entry model for atrial tachycardia in conscious dogs. Cardiovasc Res. 1989 May;23(5):400–409. doi: 10.1093/cvr/23.5.400. [DOI] [PubMed] [Google Scholar]
  18. Wu K. M., Ross S., Hoffman B. F. Monophasic action potentials during reentrant atrial flutter in the dog: effects of clofilium and acetylcholine. J Cardiovasc Pharmacol. 1989 Jun;13(6):908–914. doi: 10.1097/00005344-198906000-00014. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES